One Biosciences: Hedi Ben Brahim

Hedi Ben Brahim has been appointed as CEO of single-cell analysis firm One Biosciences, succeeding Magali Richard, who cofounded the company and will remain its chief operating officer. Ben Brahim joins Paris-based One Biosciences from Transgene, where he was CEO. Prior to that, he was VP of immunotherapy at Institut Mérieux. He holds degrees from École Polytechnique and from École Nationale Supérieure des Mines de Paris.